223 related articles for article (PubMed ID: 29787015)
1. Clinical efficacy analysis of preoperative neoadjuvant chemotherapy with high-dose dense paclitaxel plus cisplatin in Stages IB2, IIA2, IIB cervical cancer in Iran.
Mousavi AS; Hashemi FS; Gilani MM; Akhavan S; Shariat M
Eur J Gynaecol Oncol; 2016; 37(5):703-709. PubMed ID: 29787015
[TBL] [Abstract][Full Text] [Related]
2. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
[TBL] [Abstract][Full Text] [Related]
4. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K
J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
Gadducci A; Landoni F; Cosio S; Zizioli V; Zola P; Ferrero AM; Lapresa MT; Maggino T; Sartori E
Anticancer Res; 2018 Jun; 38(6):3627-3634. PubMed ID: 29848719
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: A randomized multicenter study.
Yang Z; Chen D; Zhang J; Yao D; Gao K; Wang H; Liu C; Yu J; Li L
Gynecol Oncol; 2016 May; 141(2):231-239. PubMed ID: 26115978
[TBL] [Abstract][Full Text] [Related]
7. Response to neoadjuvant chemotherapy with paclitaxel and cisplatin in locally advanced cervical cancer.
Mousavia AS; Vahidi S; Karimi-Zarchi M; Modarress-Gilania M; Ghaemmaghamia F
Eur J Gynaecol Oncol; 2013; 34(6):527-31. PubMed ID: 24601044
[TBL] [Abstract][Full Text] [Related]
8. Comparison of survival outcomes of neoadjuvant therapy and direct surgery in IB2/IIA2 cervical adenocarcinoma: a retrospective study.
Ouyang P; Cai J; Gui L; Liu S; Wu NY; Wang J
Arch Gynecol Obstet; 2020 May; 301(5):1247-1255. PubMed ID: 32221709
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer.
Nagao S; Yamamoto K; Oishi T; Yamaguchi S; Takehara K; Shimada M; Kigawa J
Int J Clin Oncol; 2021 Jan; 26(1):207-215. PubMed ID: 32960420
[TBL] [Abstract][Full Text] [Related]
10. Dose-Dense Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: A Phase II Study.
Benedetti Panici P; Palaia I; Marchetti C; Ruscito I; Fischetti M; Musella A; Di Donato V; Perniola G; Vertechy L; Muzii L
Oncology; 2015; 89(2):103-10. PubMed ID: 25924602
[TBL] [Abstract][Full Text] [Related]
11. Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
Xiong Y; Liang LZ; Cao LP; Min Z; Liu JH
Gynecol Oncol; 2011 Oct; 123(1):99-104. PubMed ID: 21741694
[TBL] [Abstract][Full Text] [Related]
12. Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB.
Minig L; Colombo N; Zanagnolo V; Landoni F; Bocciolone L; Cárdenas-Rebollo JM; Iodice S; Maggioni A
Int J Gynecol Cancer; 2013 Nov; 23(9):1647-54. PubMed ID: 24100590
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancer.
Huang Y; Chen L; Cai J; Yang L; Sun S; Zhao J; Xiong Z; Wang Z
World J Surg Oncol; 2022 Aug; 20(1):264. PubMed ID: 35996118
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical efficacy of three different neoadjuvant approaches (chemotherapy combined vaginal intracavitary irradiation, neoadjuvant chemotherapy alone or radiotherapy) combined with surgery for patients with stage Ib2 and IIa2 cervical cancer.
Fu JH; Gao Z; Ren CC; Shi YG
Asian Pac J Cancer Prev; 2013; 14(4):2377-81. PubMed ID: 23725144
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation.
Dueñas-Gonzalez A; López-Graniel C; González-Enciso A; Cetina L; Rivera L; Mariscal I; Montalvo G; Gómez E; de la Garza J; Chanona G; Mohar A
Ann Oncol; 2003 Aug; 14(8):1278-84. PubMed ID: 12881393
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer.
Liang Y; Lü W; Zhang X; Lü B
Diagn Pathol; 2018 Nov; 13(1):93. PubMed ID: 30474571
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant paclitaxel and cisplatin in uterine cervical cancer: long-term results.
Park DC; Suh MJ; Yeo SG
Int J Gynecol Cancer; 2009 Jul; 19(5):943-7. PubMed ID: 19574789
[TBL] [Abstract][Full Text] [Related]
18. [Clinical curative effects of preoperative neoadjuvant chemotherapy on cervical cancer: analysis of 62 patients].
He CM; Liang FB; Chen ML; Wu XM; Jin S
Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(5):327-9. PubMed ID: 22490837
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer.
Benedetti-Panici P; Greggi S; Scambia G; Amoroso M; Salerno MG; Maneschi F; Cutillo G; Paratore MP; Scorpiglione N; Mancuso S
Eur J Cancer; 1998 Feb; 34(3):341-6. PubMed ID: 9640219
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for Stage IB2-IIB cervical cancer--irinotecan and platinum chemotherapy.
Matsumura M; Takeshima N; Ota T; Omatsu K; Sakamoto K; Kawamata Y; Umayahara K; Tanaka H; Akiyama F; Takizawa K
Gynecol Oncol; 2010 Nov; 119(2):212-6. PubMed ID: 20709382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
